“Good Health Can’t Wait”: Innovation at Dr Reddy ’s Laboratories
What strategic and industry insights can be gleaned from Dr Reddy’s Laboratories’ (DRL) transformation from a big pharmaceutical vendor to generic drug manufacturer? DRL Co-Chairman and Chief Executive Officer GV Prasad talked to Professor Sarang Deo, Executive Director of the Max Institute of Healthcare Management at the Indian School of Business.
Read more
